Editor's note - Page 6 of 20 - Express Pharma

Why we need an Aatmanirbhar booster strategy

With Omicron, the SARS-CoV-2 virus ups the ante

The Covaxin-WHO EUL saga

Biocon Biologics-SII alliance should balance business and public health

Is India’s pharma sector being penalised for its success?

Not independent, but more inter-dependent than ever before

PharmEasy-Thyrocare deal milestone for e-pharmacy sector

Preparing for the third wave

No more the pharmacy/vaccine maker of the world?

India Vaccine Inc’s Achilles heel